← Leaderboards
Jin Chen
Veterans Health Administration
$15,493,845
Attributed
$17,912,708
Total exposure
13
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,912,708 · 11
VA$0 · 2
By mechanism
R01$12,638,524 · 7
T32$4,330,386 · 1
P30$588,164 · 2
R21$355,634 · 1
I01$0 · 1
IK6$0 · 1
Top collaborators
- Dana M Brantley-Sieders7 shared
- Mark R. Boothby5 shared
- Deyu Li2 shared
- Donna J Webb2 shared
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsTumorCellsAffectSuccessSignal TransductionNeoplastic CellIn VivoTumor GrowthCancer CellNeoplasm MetastasisSignal PathwayMediatingMolecularTumor ProgressionPathway InteractionsInvestigationRefractoryPlayKinase InhibitorNew Therapeutic TargetBlood VesselsMutantInhibitor/Antagonist
Grant awards (82)
Vascular regulation of fatty acid transport in metastatic tumor outgrowth$505,681
R01 · FY2025 · CA · contact PI
Cancer Cell Biology Research Program$339,812
P30 · FY2025 · CA · contact PI
Targeting mTORC2 in lung squamous cancer$0
I01 · FY2025 · VA · contact PI
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2025 · VA · contact PI
Vascular regulation of fatty acid transport in metastatic tumor outgrowth$480,397
R01 · FY2024 · CA · contact PI
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC$468,519
R01 · FY2024 · CA · contact PI
Cancer Cell Biology Research Program$82,784
P30 · FY2024 · CA · contact PI
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2024 · VA · contact PI
Targeting mTORC2 in lung squamous cancer$0
I01 · FY2024 · VA · contact PI
Vascular regulation of fatty acid transport in metastatic tumor outgrowth$505,681
R01 · FY2023 · CA · contact PI
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC$483,313
R01 · FY2023 · CA · contact PI
Cancer Cell Biology Research Program$82,784
P30 · FY2023 · CA · contact PI
Targeting mTORC2 in lung squamous cancer$0
I01 · FY2023 · VA · contact PI
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2023 · VA · contact PI
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC$483,313
R01 · FY2022 · CA · contact PI
Microenvironmental Influences in Cancer$449,242
T32 · FY2022 · CA · contact PI
Cancer Cell Biology Research Program$82,784
P30 · FY2022 · CA · contact PI
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2022 · VA · contact PI
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC$493,176
R01 · FY2021 · CA · contact PI
Microenvironmental Influences in Cancer$438,353
T32 · FY2021 · CA · contact PI
Role of mLST8 in mTORC2-dependent lung cancer that are refractory to targeted therapies$0
I01 · FY2021 · VA · contact PI
BLRD Merit Review Research Career Scientist (RCS) Award (IK6)$0
IK6 · FY2021 · VA · contact PI
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC$493,176
R01 · FY2020 · CA · contact PI
Microenvironmental Influences in Cancer$434,887
T32 · FY2020 · CA · contact PI
Role of mLST8 in mTORC2-dependent lung cancer that are refractory to targeted therapies$0
I01 · FY2020 · VA · contact PI
Microenvironmental Influences in Cancer$426,752
T32 · FY2019 · CA · contact PI
Endothelial mTOR signaling in tumor-blood vessel interaction$310,106
R01 · FY2019 · CA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$46,888
R01 · FY2019 · CA · contact PI
Role of mLST8 in mTORC2-dependent lung cancer that are refractory to targeted therapies$0
I01 · FY2019 · VA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$379,993
R01 · FY2018 · CA · contact PI
Endothelial mTOR signaling in tumor-blood vessel interaction$319,698
R01 · FY2018 · CA · contact PI
Role of mLST8 in mTORC2-dependent lung cancer that are refractory to targeted therapies$0
I01 · FY2018 · VA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$379,993
R01 · FY2017 · CA · contact PI
Endothelial mTOR signaling in tumor-blood vessel interaction$319,698
R01 · FY2017 · CA · contact PI
Microenvironmental Influences in Cancer$302,659
T32 · FY2017 · CA · contact PI
Microenvironmental Influences in Cancer$1,296
T32 · FY2017 · CA · contact PI
Targeting EphA2 in lung cancer subtypes that are refractory to current therapy$0
I01 · FY2017 · VA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$379,993
R01 · FY2016 · CA · contact PI
Microenvironmental Influences in Cancer$306,232
T32 · FY2016 · CA · contact PI
Endothelial mTOR signaling in tumor-blood vessel interaction$235,619
R01 · FY2016 · CA · contact PI
Endothelial mTOR signaling in tumor-blood vessel interaction$82,058
R01 · FY2016 · CA · contact PI
Targeting EphA2 in lung cancer subtypes that are refractory to current therapy$0
I01 · FY2016 · VA · contact PI
Endothelial mTOR signaling in tumor-blood vessel interaction$372,157
R01 · FY2015 · CA · contact PI
Microenvironmental Influences in Cancer$362,643
T32 · FY2015 · CA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$189,380
R01 · FY2015 · CA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$188,212
R01 · FY2015 · CA · contact PI
Targeting EphA2 in lung cancer subtypes that are refractory to current therapy$0
I01 · FY2015 · VA · contact PI
Microenvironmental Influences in Cancer$387,334
T32 · FY2014 · CA · contact PI
ephrin-A1 in lipogenesis and breast cancer metastatic progression$377,592
R01 · FY2014 · CA · contact PI
Microenvironmental Influences in Cancer$29,456
T32 · FY2014 · CA · contact PI
Targeting EphA2 in lung cancer subtypes that are refractory to current therapy$0
I01 · FY2014 · VA · contact PI
Microenvironmental Influences in Cancer$377,751
T32 · FY2013 · CA · contact PI
Microenvironmental Influences in Cancer$28,977
T32 · FY2013 · CA · contact PI
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors$0
I01 · FY2013 · VA · contact PI
Microenvironmental Influences in Cancer$380,850
T32 · FY2012 · CA · contact PI
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis$291,193
R01 · FY2012 · CA · contact PI
VEC3-Valve Enabled Cell Co-Culture Platforms for Cancer Biology Study$194,002
R21 · FY2012 · CA
Microenvironmental Influences in Cancer$29,931
T32 · FY2012 · CA · contact PI
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors$0
I01 · FY2012 · VA · contact PI
Microenvironmental Influences in Cancer$336,559
T32 · FY2011 · CA · contact PI
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis$291,193
R01 · FY2011 · CA · contact PI
VEC3-Valve Enabled Cell Co-Culture Platforms for Cancer Biology Study$161,632
R21 · FY2011 · CA
Microenvironmental Influences in Cancer$37,464
T32 · FY2011 · CA · contact PI
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors$0
I01 · FY2011 · VA · contact PI
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis$300,198
R01 · FY2010 · CA · contact PI
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis$297,896
R01 · FY2009 · CA · contact PI
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell$287,453
R01 · FY2009 · CA · contact PI
Role of EphA2 RTK in tumor resistance to EGFR/HER2 inhibitors$0
I01 · FY2009 · VA · contact PI
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis$295,593
R01 · FY2008 · CA · contact PI
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell$287,453
R01 · FY2008 · CA · contact PI
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell$287,219
R01 · FY2007 · CA · contact PI
Eph receptor tyrosine kinases in tumor angiogenesis$286,708
R01 · FY2007 · CA · contact PI
Eph receptor tyrosine kinases in tumor angiogenesis$295,271
R01 · FY2006 · CA · contact PI
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell$294,592
R01 · FY2006 · CA · contact PI
Eph receptor tyrosine kinases in tumor angiogenesis$302,378
R01 · FY2005 · CA
EphA2 Receptor Tyrosine Kinase in Malignant Tumor Cell$299,706
R01 · FY2005 · CA
Eph receptor tyrosine kinases in tumor angiogenesis$302,378
R01 · FY2004 · CA
Eph receptor tyrosine kinases in tumor angiogenesis$302,378
R01 · FY2003 · CA
ECK RECEPTOR TYROSINE KINASE IN HINDBRAIN DEVELOPMENT$131,475
R01 · FY2002 · HD
ECK RECEPTOR TYROSINE KINASE IN HINDBRAIN DEVELOPMENT$224,036
R01 · FY2001 · HD
SIGNALS FOR RENAL ENDOTHELIAL CAPILLARY MORPHOGENESIS$196,734
R01 · FY2001 · DK
ECK RECEPTOR TYROSINE KINASE IN HINDBRAIN DEVELOPMENT$170,027
R01 · FY2000 · HD